tm logo
INFACELL
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 16 Mar 2023

Last Applicant/ Owned by

3530 JOHN HOPKINS COURT

SAN DIEGO

CA

92121

Serial Number

86980437 filed on 27th Mar 2015

Registration Number

5075245 registered on 01st Nov 2016

in the Principal Register

Correspondent Address

Alicia M. Passerin

Alicia M. Passerin

525 William Penn Place, 28th Floor

Pittsburgh PA 15219

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

INFACELL

Cell-derived preparations for clinical, medicinal, therapeutic, and veterinary purposes Cells and cell-derived preparations for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research

Classification Information


Class [001]
Chemical Products


Cells and cell-derived preparations for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research


First Use Date in General

29th Aug 2016

First Use Date in Commerce

29th Aug 2016

Class [005]
Pharmaceutical Products


Cell-derived preparations for clinical, medicinal, therapeutic, and veterinary purposes


First Use Date in General

29th Aug 2016

First Use Date in Commerce

29th Aug 2016

Mark Details


Serial Number

No 86980437

Mark Type

No Service/Collective Mark

Attorney Docket Number

No NKW-13A

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
16th Mar 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16th Mar 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
16th Mar 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
31st Aug 2022TEAS SECTION 8 & 15 RECEIVED
01st Nov 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09th Jun 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
27th Apr 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27th Apr 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01st Nov 2016REGISTERED-PRINCIPAL REGISTER
30th Sep 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED